Technical Description
The invention presents a lipophilic cholinesterase inhibitor, an oxadiazole piperazine compound, synthesized from benzoic acid derivatives and hydrazine, offering high for neurodegenerative conditions.
Problems Addressed
- Ester Group Limitation
- Structural Instability
- Costly Sourcing
- Unsustainable Process
Tech Features
- Lipophilic Inhibitor
- Enhanced Affinity
- Brain-penetrating Capability
- Cost Effective
- Eco Friendly
Target Audience
- Pharmaceutical Industry
- Biotechnology Sector
- Healthcare
- Research & Development
Tech ID: P21-1904 TRL 4 Patent Status: Published Available For Exclusive and Non-exclusive License
